
Bioorganic and Medicinal Chemistry Letters p. 1791 - 1796 (1998)
Update date:2022-09-26
Topics:
Chambers
Antognoli
Cheng
Marfat
Pillar
Shirley
Watson
By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical LTD4 antagonists Zafirlukast (1) and Pranlukast (2).
View MoreContact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Chengdu Baishixing Science and Technology Industry Co., Ltd.
website:http://www.cd-bsx.com
Contact:+86-28-88531548
Address:#217,North of Industry Road,Heshan Town,Pujiang County,Chengdu,Sichuan,China.
Hangzhou Yingshanhua Pigment Chemicals Co.,Ltd.
Contact:+86-0150-58101658
Address:Nanyang Economic DevelopmentZong,Xiaoshan,Hangzhou,China
puyang hongda shengdao new material co.,ltd.
Contact:+86-393- 4896278
Address:No.29 East Zhongyuan Road
Shanghai Pengkai Chemical Co.,Ltd
Contact:+86-21-60526671
Address:No.4226 Duzhuang Rd Minhang District Shanghai China
Doi:10.1016/S0040-4039(97)01002-2
(1997)Doi:10.1039/a807718e
(1999)Doi:10.1002/hlca.19970800424
(1997)Doi:10.1021/acs.organomet.7b00603
(2018)Doi:10.1016/S0040-4020(97)00526-7
(1997)Doi:10.1021/jo970548x
(1997)